GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Total Long-Term Liabilities

ASKA Pharmaceutical Holdings Co (TSE:4886) Total Long-Term Liabilities : 円12,947 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is ASKA Pharmaceutical Holdings Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. ASKA Pharmaceutical Holdings Co's Total Long-Term Liabilities for the quarter that ended in Dec. 2023 was 円12,947 Mil.

ASKA Pharmaceutical Holdings Co Total Long-Term Liabilities Historical Data

The historical data trend for ASKA Pharmaceutical Holdings Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASKA Pharmaceutical Holdings Co Total Long-Term Liabilities Chart

ASKA Pharmaceutical Holdings Co Annual Data
Trend Mar22 Mar23 Mar24
Total Long-Term Liabilities
18,395.00 14,957.00 4,848.00

ASKA Pharmaceutical Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,957.00 13,615.00 13,265.00 12,947.00 4,848.00

ASKA Pharmaceutical Holdings Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

ASKA Pharmaceutical Holdings Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of ASKA Pharmaceutical Holdings Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

ASKA Pharmaceutical Holdings Co (TSE:4886) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Total Long-Term Liabilities
Comparable Companies
TSE:2929 TSE:4577 TSE:9273 TSE:4554 TSE:4595 TSE:4538 TSE:4574 TSE:4582 TSE:4524 TSE:4512 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532
Website
https://www.aska-pharma-hd.co.jp
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.

ASKA Pharmaceutical Holdings Co (TSE:4886) Headlines

No Headlines